Gimv Investeringsmaatschappij Voor Vlanderen NV operates within the Investors sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Gimv Investeringsmaatschappij Voor Vlanderen NV with three other
financial institutions in Europe:
sales of 762.70 million Swedish Kronor [US$86.68 million]
of which 100%
was Investment Activities),
MedCap AB (publ)
(816.92 million Swedish Kronor [US$92.84 million]
of which 74%
was Unimedic), and
Deutsche Beteiligungs AG
based in Germany
(85.21 million Euro [US$92.01 million]
of which 71%
was Private Equity Investments).
During the year ended March of 2016, sales at
Gimv Investeringsmaatschappij Voor Vlanderen NV were 103.76 million Euro (US$112.06 million).
decrease of 20.0%
versus 2015, when the company's sales were 129.63 million Euro.
Contributing to the drop in overall sales was the 61.8% decline
in Sustainable Cities, from 18.56 million Euro to 7.09 million Euro.
There were also decreases in sales in
Health and Care (down 35.2% to 36.98 million Euro)
Consumer (down 11.8% to 12.14 million Euro)
Other (down 48.1% to 15.24 million Euro)
However, these declines were partially offset by the increase in sales of
Smart Industries (up 27.4% to 33.74 million Euro)